Publication:
Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds

dc.contributor.authorsKucukguzel, SG; Oruc, EE; Rollas, S; Sahin, F; Ozbek, A
dc.date.accessioned2022-03-12T17:00:06Z
dc.date.accessioned2026-01-10T18:32:47Z
dc.date.available2022-03-12T17:00:06Z
dc.date.issued2002
dc.description.abstractTwo novel series of 4-thiazolidinone derivatives namely 2-substituted-3-{[4-(4-methoxybenzoylamino)benzoyl]amino}-4-thiazolidinones (7a-e) and 2-[4-(4-methoxybenzoylamino)benzoylhydrazono]-3-alkyl-4-thiazolidinones (5a-c) together with 2-[4-(4-methoxybenzoylamino)phenyl]-5-(substituted phenyl)amino-1,3,4-oxadiazoles (6a-c) have been synthesised as title compounds. N-1-[4-(4-methoxybenzoylamino)benzoyl]-N-2-substituted methylene hydrazines (3a-e) and 1-[4-(4-methoxybenzoylamino)benzoyl]4-substituted phenyl thiosemicarbazides (4a-f) were also prepared and used as intermediate to give the title compounds. All synthesised compounds were screened for their antimycobacterial activity against Mycobacterium tuberculosis H37Rv and antimicrobial activities against various bacteria and fungi. Compounds 7a and 7b were found as the most active derivatives demonstrating 90 and 98% inhibition of mycobacterial growth of M. tuberculosis H37Rv, in the primary screen at 6.25 mug mL(-1), respectively. However, level 11 assay revealed that the MIC values were not less than 6.25 mug mL(-1). None of the compounds showed significant antimicrobial activity against the microorganisms used whereas 3a and 7a inhibited the growth of several bacteria and fungi. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
dc.identifier.doi10.1016/S0223-5234(01)01326-5
dc.identifier.eissn1768-3254
dc.identifier.issn0223-5234
dc.identifier.pubmed11900864
dc.identifier.urihttps://hdl.handle.net/11424/227277
dc.identifier.wosWOS:000175282700002
dc.language.isoeng
dc.publisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
dc.relation.ispartofEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subject4-thiazolidinone
dc.subject1,3,4-oxadiazole
dc.subjecthydrazide-hydrazone
dc.subjectthiosemicarbazide
dc.subjectantimycobacterial activity
dc.subjectBACTEC 460 radiometric system
dc.subjectANTICONVULSANT ACTIVITY
dc.subjectANTIMICROBIAL ACTIVITY
dc.subjectANTIFUNGAL ACTIVITY
dc.subjectDERIVATIVES
dc.titleSynthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage206
oaire.citation.issue3
oaire.citation.startPage197
oaire.citation.titleEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
oaire.citation.volume37

Files